• photo

    Annual charge exemption scheme

    The annual charge exemption scheme replaced the low value turnover scheme on 1 July 2015
  • people around a laptop

    TGA Business Services site

    The upgraded TGA Business Services site is an improved way for industry to do business with the TGA
  • photo of apple and tablets

    Food-Medicine Interface Guidance Tool (FMIGT)

    TGA has developed a tool to help determine if products are regulated as food or a medicine
  • Expert review of medicines and medical device regulation

    Expert review of medicines and medical device regulation

    Stage One Report on the Regulatory Framework for Medicines and Medical Devices released
  • new chemical entity image

    Registration of new chemical entities in Australia

    Each year, approximately 40 new prescription medicines containing new active substances are registered

Consumers

Patient, carer, traveller, visitor...

Do you use or buy therapeutic goods?

Health professionals

Doctor, nurse, pharmacist...

Do you prescribe or use therapeutic goods as a professional?

Industry

Sponsor, manufacturer...

Do you supply or manufacture therapeutic goods, or want to?

Safety information

Subscribe to TGA safety information
4 August 2015
Recall for product correction - potential for interruption of insulin delivery and/or infection due to needle breaking during use
3 August 2015
Update - additional products affected
3 August 2015
Recall - risk of plastic fragments breaking from bottle and being ingested
3 August 2015
In this issue: risperidone and risk of cerebrovascular adverse events; infliximab and non-melanoma skin cancers; tramadol oral drops

More safety information »

News

Subscribe to TGA latest news and updates
30 July 2015
We will continue our efforts to clear the current backlog of GMP Clearance applications and provide you with updates on progress
30 July 2015
The TGA has become aware of issues affecting documentation attached to some GMP clearance applications
28 July 2015
Submissions received on the Orphan drugs program consultation have been published
28 July 2015
Added Umeclidinium bromide (Incruse Ellipta)

More news »